Sign in

CIK 0001160308

  • Non-accelerated filer
  • Smaller reporting company
Ticker
SVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841318182
Phone
+51 285113796
Business address
6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
Former names
Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-01-02 Lowrance David L Chief Financial Officer Exercise or conversion +31,894 $1.51 $48K 33,994
2018-01-02 Lowrance David L Chief Financial Officer Shares withheld for taxes −3,239 $15.06 $49K 30,755
2018-01-02 Lowrance David L Chief Financial Officer Exercise or conversion · Employee Stock Option (right to buy) −31,894 95,684
2017-12-17 Elam Nevan C Director Grant or award · Stock Option (Right to Buy) +3,750 3,750
2017-12-17 McCracken Joseph S Director Grant or award · Stock Option (Right to Buy) +3,750 3,750
2017-12-17 PIKOVER YURI Director Grant or award · Stock Option (Right to Buy) +3,750 3,750
2017-12-17 Hawkins Richard J Director Grant or award · Stock Option (Right to Buy) +3,750 3,750
2017-10-27 PIKOVER YURI Director Purchase +50,000 $7.85 $393K 150,000
2017-06-07 Neville Robert N Chief Executive Officer Purchase +52,250 $4.75 $248K 430,385
2017-06-07 RAMSAY DAVID A Director Purchase +21,000 $4.75 $100K 22,428
2017-06-07 PIKOVER YURI Director Purchase +100,000 $4.75 $475K 100,000
2017-06-07 Jouhikainen Jaakko Taneli Purchase +10,500 $4.75 $50K 235,326
2017-06-07 Lowrance David L Chief Financial Officer Purchase +2,100 $4.75 $10K 2,100
2017-06-07 McCracken Joseph S Director Purchase +52,250 $4.75 $248K 59,866
2017-05-25 RAMSAY DAVID A Director Grant or award · Stock Option (Right to Buy) +3,750 3,750
2017-05-25 Pauls Matthew Director Grant or award · Stock Option (Right to Buy) +3,750 3,750
2017-04-27 Pauls Matthew Exercise or conversion +650 650
2017-04-27 Pauls Matthew Exercise or conversion · Restricted Stock Units −650 0
2017-04-27 RAMSAY DAVID A Director Exercise or conversion +1,142 23,570
2017-04-27 RAMSAY DAVID A Director Exercise or conversion · Restricted Stock Units −1,142 0

Page 19 of 20 · 390 trades